
RDCA-DAP Scientific Director @CPathInstitute, patient advocate, neuroscientist, and proud mom. Opinions are my own.
Colorado
Joined March 2017
- Tweets3.1K
- Following2.3K
- Followers1.6K
- Likes6.6K
Congratulations to Dr. Michela Faglioni of BCH and co-PI, Dr. Annarita Patrizi, of the German Cancer Research Center! @CDKL5_IFCR is proud to partner with @MDBRide4Rare to fund this international research collaboration.
Congrats to the 2022 #MDBR grant awardees! 37 projects were funded with $2.6M raised for 30 #rarediseases. Thank you to our MDBR community for their fundraising & commitment to the cause. See the full list of projects here: https://teapaw.org/t.co/tAH8qoEZZ3
Congratulations to Drs. Jacinta Saldaris, Isabel Haviland, and Joni Saby on your #CDKL5 Forum Junior Investigator Awards! Thank you for your valuable work in the International CDKL5 Clinical Research Network.
2
12
Replying to @LalDennis
@LalDennis presents the need for variant interpretation to understand potential therapy response @cacna1a conference.
Decisions are made with incomplete information.
Likens the surgical resections in lesional epilepsy and progress to better predict 70% response rate.
@CDKL5USA is grateful to @MMeskis, @_katehintz, and the whole @curedravet crew for their mentorship!
Dravet Syndrome is more than just seizures. Learn more at: dravetsyndrome.org
#DravetSyndromeAwarenessDay
2
Miles went untracked, but the kids moved, and we went on a starfish-finding tour.
justgiving.com/fundraising/h…
#CDKL5awarenessDay
3
The amazing @CDKL5AdvocacyM discusses the challenges of supporting the entire family, especially her #CDKL5 Deficiency Disorder child's siblings over time. "It is not just happening to me, it's happening to us all."
#CDKL5awareness #CDKL5FamilyConference
All recordings from the first day of CANDID are already available for registrants:
1) Click the "Go to my event" button below
2) Login with the name and email used for registration
3) select "Schedule" at the top of the home page, and click "On Demand."
Replying to @CDKL5_IFCR
@CDKL5USA has partnered with the Consortium for Autism, Neurodevelopmental Disorders & Digestive Diseases (CANDID) on a conference about gastrointestinal issues in individuals with #neurodevelopmental disorders 🧵
It's #SCN2A Awareness Day. Catch up on @FamilieSCN2A tweets or check out scn2a.org.
-The varied SCN2A clinical phenotypes are depend on the SCN2A gene variant location AND the functional change observed in the voltage-gated sodium ion channel, Nav1.2.
On #WomenInScience Day, the thing that fills me with the most pride is a daughter who sends pics of sheep brains and eyeballs from middle school science class. Tough, kind, and curious. I did something right during my academic training.
2
9
Happy International Phelan-McDermid Syndrome Awareness Day 2021!
For more information about Phelan-McDermid syndrome, visit pmsf.org
#PMSAD #pmsf #phelanmcdermid
4
Challenges for CNS treatment:
-early treatment is required
-treatment exhibits limited reversibility
-to demonstrate an effect, need large n (lots of patients)
-biomarkers may change at any stage, but clinical benefit is uncertain, thus, "unproven" as primary endpoint.
Same treatment effect, but variable clinical outcome possible. Why?
Emil Kakkis presents a conceptual model that addresses the potential for surrogate biomarkers and the degrees of reversibility depending on stage, severity, and, progression.
@EveryLifeOrg
🟣Event Date: Friday October 22, 2021
🟣Event Time: 3:00pm – 6:00pm CT (virtual forum opens at 2:45pm)
The latest research in co-occurring epilepsy and Rett Spectrum disorders and more. . .
➡Learn more and register here: iddrc.wustl.edu/rett/
Reliability improves when scales are simplified and clear criteria are defined for raters. #LGS
2
@DrZachGrinspan continued to describe the challenges of inter-rater reliability among experts within and across institutions (a roadblock for natural history studies and clinical trials, especially when identifying challenging events like hypsarrhythmia EEG).
1
2
Replying to @LGS_Foundation
@LGS_Foundation held a fantastic first round of #TheMeetingOfTheMinds today. Impactful presentations on how to apply context to health data science and clinical trial design.
*ONLY 33/75 candidate patient medical records provided useful data for future studies.






















